83,86 This difference can be attributed to several factors, such as the non-availability of many non-GLP-1 receptor analogs, limited access to AOMs in public hospitals, limited knowledge among healthcare providers, and a limited number of obesity specialists
Some GLP-1 receptor agonists, particularly semaglutide, reduced the risk for worsening mental health in people with anxiety or depression, data show
If youre on insulin, be aware of low blood sugar symptoms such as dizziness, weakness, fatigue, shakiness, sweating, rapid heart rate, and anxiety
Proteobacteria: microbial signature of dysbiosis in gut microbiota
Favorece la definicin muscular al reducir grasa subcutnea
Short-term use is not recommended